CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395 | +44 (0) 20 3951 8071
info@oxonepi.com

White Paper RWE needs in Oncology: Gastroesophageal Cancer

Gastro-Cancer

REAL WORLD EVIDENCE NEEDS IN ONCOLOGY:
Gastroesophageal Cancer

White Paper based on new trial results from ESMO Congress, 20-24 October 2023, Madrid.

The varying nature of gastroesophageal cancer, spanning from localized, indolent tumors to aggressive, metastatic forms, coupled with the emergence of resistance to established treatments, emphasizes the urgent requirement for ongoing research and clinical trials aimed at improving patient outcomes.

OXON’s assessment of the research findings presented at ESMO 2023 and their potential implications for existing clinical protocols and practices offers a thorough insight, assisting in pinpointing the real-world evidence (RWE) deficiencies in the management of gastroesophageal cancer.

    Your details: Fields marked with an asterisk (*) are required.

    First Name*

    Last Name*

    Work Email address*

    Company*

    Department*

    Position*

    Therapeutic Area*

    Country*

    As responsible for the processing of the personal data you provide, OXON informs you that your data will be processed in accordance with the provisions of the laws in force related to data protection and notably the General Data Protection Regulation 2016/679. Your data will be used to establish or maintain a business relationship and sending you communications about our services. The data will be kept as long as there is a legitimate interest. As a data subject, you will have the right to withdraw your consent at any time. You will also have the right to access, to rectify, to erase your personal data as well as the right to ask for its portability or the limitation of its processing.